Copyright(c)2017 Qilu Pharmaceutical Co., Ltd. 鲁ICP备06006222号 Headquarter Address: 243 Gong Ye Bei Road, Jinan, Shandong 250100, CHINA
Qilu Pharmaceutical (Inner Mongolia) Passes U.S. FDA Inspection
The USFDA has completed the GMP compliance inspection of Qilu Pharmaceutical (Inner Mongolia), a subsidiary of Qilu Pharma Group. The inspection commenced on April 9, 2018, and was completed on April 12, 2018. All quality systems were evaluated in the inspection, and the facility received a successful response with ZERO FDA 483 observations.The good inspection results speak to our commitment to high standards of quality and excellence.It is the first FDA inspection for Inner Mongolia facilities, which represents an important milestone for the company to enter the US market.